Cellectar Biosciences, Inc. Annual Operating Income (Loss) in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Cellectar Biosciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
  • Cellectar Biosciences, Inc. Operating Income (Loss) for the quarter ending March 31, 2024 was -$12M, a 37.9% decline year-over-year.
  • Cellectar Biosciences, Inc. Operating Income (Loss) for the twelve months ending March 31, 2024 was -$42.3M, a 34.7% decline year-over-year.
  • Cellectar Biosciences, Inc. annual Operating Income (Loss) for 2023 was -$39M, a 35.2% decline from 2022.
  • Cellectar Biosciences, Inc. annual Operating Income (Loss) for 2022 was -$28.8M, a 19.4% decline from 2021.
  • Cellectar Biosciences, Inc. annual Operating Income (Loss) for 2021 was -$24.1M, a 57.8% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$39M -$10.1M -35.2% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-27
2022 -$28.8M -$4.68M -19.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-27
2021 -$24.1M -$8.84M -57.8% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 -$15.3M -$1.11M -7.84% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-21
2019 -$14.2M -$848K -6.36% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-02
2018 -$13.3M +$270K +1.99% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-09
2017 -$13.6M -$4.15M -43.9% Jan 1, 2017 Dec 31, 2017 10-K 2019-02-26
2016 -$9.45M -$692K -7.9% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-21
2015 -$8.76M +$1.13M +11.5% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-15
2014 -$9.89M +$2.51M +20.2% Jan 1, 2014 Dec 31, 2014 10-K/A 2016-10-20
2013 -$12.4M -$3.65M -41.7% Jan 1, 2013 Dec 31, 2013 10-K/A 2015-05-20
2012 -$8.75M -$1.72M -24.4% Jan 1, 2012 Dec 31, 2012 10-K 2014-03-19
2011 -$7.04M -$2.84M -67.8% Jan 1, 2011 Dec 31, 2011 10-K 2013-03-28
2010 -$4.19M Jan 1, 2010 Dec 31, 2010 10-K 2012-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.